Clinical Trial Update: Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 clinical trial comparing phlebotomy versus erythrocytapheresis for management of hereditary hemochromatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis

Snippet

Sponsor: San Filippo Neri General Hospital | Conditions: Hereditary Hemochromatosis | Phase 2, Phase 3 | Status: COMPLETED